Increased expression of specific calcium channels in some cancers and the role of calcium signaling in proliferation and invasion have led to studies assessing calcium channel inhibitors as potential therapies for some cancers. The use of channel activators to promote death of cancer cells has been suggested, but the risk of activators promoting cancer cell proliferation and the importance of the degree of channel over-expression is unclear. We developed an MCF-7 breast cancer cell line with inducible TRPV1 overexpression and assessed the role of TRPV1 levels on cell death mediated by the TRPV1 activator capsaicin and the potential for submaximal activation to promote proliferation. The TRPV1 level was a determinant of cell death induced by capsaicin. A concentration response curve with varying TRPV1 expression levels identified the minimum level of TRPV1 required for capsaicin induced cell death. At no level of TRPV1 over-expression or capsaicin concentration did TRPV1 activation enhance proliferation. Cell death induced by capsaicin was necrotic and associated with up-regulation of c-Fos and RIP3. These studies suggest that activators of specific calcium channels may be an effective way to induce necrosis and that this approach may not always be associated with enhancement of cancer cell proliferation.
In prostate cancer cells, Zhang and Barritt [17] demonstrated that silencing TRPM8 reduces cell viability and induces apoptosis in LNCaP cells, and that activation of TRPM8 with the non-selective TRPM8 activator menthol [23] also reduces cell viability and induces apoptosis [17] . Menthol also induces cell death, but not apoptosis, in a bladder cancer cell line with elevated levels of TRPM8 [24] . Transient expression of the drosophila TRPL (constitutively active) in the LNCaP cells reduces cell viability and increases apoptosis [25] . Activation of overexpressed TRPV2 in a bladder cancer cell line with cannabidiol and activation of overexpressed TRPV1 with capsaicin in a lung cancer cell line both cause apoptosis [26, 27] .
One potential limitation of activating an overexpressed calcium permeable ion channel as a therapeutic approach for cancer therapy is the possibility of the activator producing levels of Ca 2+ influx that are not sufficient to induce cell death, but which activate calcium sensitive cell cycle pathways [28] and thus promote proliferation. It is also still unclear how the level of calcium channel overexpression may influence the sensitivity of cancer cells to cell death via channel activation. In these studies we explored these issues using MCF-7 breast cancer cells with inducible TRPV1 over-expression. TRPV1 is a calcium permeable ion channel expressed in sensory neurons [29] , keratinocytes [30] and lung cells [26] , with a role in the sensing of elevated temperatures, thermal pain [31] and regulating inflammation and neurogenesis [32] . TRPV1 is activated by the hot component of chili peppers capsaicin and is sensitive to a variety of pharmacological activators and inhibitors, which have often been developed as part of the search for novel therapies for pain [33] and overactive bladder [34] .
Elevated TRPV1 expression occurs in colon [35] , pancreatic [36] and prostate [37, 38] cancer cells. Studies of capsaicin have reported varying effects, which may be related to non-TRPV1-mediated responses of capsaicin or differences between the levels of TRPV1
expression amongst different cancer cell lines. In the LNCaP prostate cancer cell line capsaicin induces cell proliferation via TRPV1 [39] , whereas in PC-3 prostate cancer cells capsaicin inhibits cell proliferation via a mechanism independent of TRPV1 [40] .
In these studies we investigated the hypotheses that cell death mediated by pharmacological activation of TRPV1 in MCF-7 breast cancer cells is dependent on both the level of TRPV1 overexpression and the concentration of TRPV1 activator, and that the overexpression of TRPV1 and submaximal activation of TRPV1 promotes the proliferation of MCF-7 breast cancer cells. We also sought to define the nature of cell death associated with TRPV1 activation in MCF-7 breast cancer cells.
Methods

Cell culture
The MCF-7 Tet-off breast cancer cell line (Clontech) and the MCF-7 parental breast cancer cell line (ATCC) were cultured in Dulbecco's Modified Eagle Medium, (high glucose) (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (FBS; Sigma Aldrich), 4 mM L-glutamine (Invitrogen), and penicillin G (100U/mL)/ streptomycin sulphate (100 g/mL; Invitrogen) at 37°C with 5% CO 2 . Cells were supplemented with G418 (100 g/mL; Invitrogen), hygromycin B (110 g/mL; Invitrogen) and doxycycline (dox; 1 g/mL; SigmaAldrich) as required. Cells were passaged when the density reached approximately 80%. The MCF-7 Tet-off TRPV1 cell line was cultured for less than 10 passages prior to experimentation.
Molecular cloning and development of MCF-7 Tet-off TRPV1 cell line
TRPV1 was amplified from pcDNA3.1 D/V5-His-TOPO-TRPV1 (a generous gift from A/Prof C Reilly, University of Utah) [26] using Platinum Pfx DNA polymerase (Invitrogen) and the following primers; forward primer GCATATATGTCGACACCATGAAGAAATGGA-GCAGCA and reverse primer GCATATATGTCGACTCACTTCTCCCCGGAAGCGGC-AGGACTCTT. The TRPV1
PCR product was ligated into the pGEM-T Easy vector (Promega) then sub-cloned into the pBI-G Tet response plasmid (Clontech). The pGEM-TRPV1 and pBI-G-TRPV1 plasmids were verified using restriction digest and nucleotide sequencing. The pBI-G-TPRV1 plasmid expresses both TRPV1 and β-galactosidase from a bidirectional promoter (Clontech).
To generate an MCF-7 Tet-Off cell line stably expressing TRPV1, cells were co-transfected with the pBI-G-Tet-off-TRPV1 response plasmid and the pTK-Hyg selection plasmid (Clontech) using LipofectAMINE 2000 (Invitrogen). Two days after transfection hygromycin (110 µg/mL) and dox (1 µg/mL) were added to the culture medium to select for transfected cells. Hygromycin resistant colonies were expanded into 24-well plates and screened for dox regulated β-galactosidase (β-gal) activity.
-Gal assay
The β-galactosidase Enzyme Assay System (Promega) was used to evaluate dox-regulated β-gal activity in MCF-7 Tet-Off TRPV1 cell lines, since β-gal is an indirect reporter for TRPV1 expression. Briefly, cells were seeded in 96-well plates (8 x 10 3 cells/well) with vehicle or dox (1 µg/mL). After 96 h cells were lysed with reporter lysis buffer for 15 min at room temperature and then incubated with assay buffer for 30 min at 37°C. Absorbance was measured at 415 nm using a Bio-Rad model 550 microplate reader.
Real-time RT-PCR
RNA was isolated from the MCF-7 Tet-Off cells using a Qiagen RNeasy plus mini kit (Qiagen). RNA was reverse transcribed using the Omniscript RT kit (Qiagen) and real-time RT-PCR was performed using TaqMan Universal PCR Master Mix or Taqman Fast
Universal Master Mix and TaqMan gene expression assays; TRPV1 (Hs00218912_m1), cFos (Hs00170630_m1), RIP3 (Hs00819388_m1) and 18S rRNA (4319413E). The real-time PCR reactions were performed using an ABI PRISM 7500 Sequence Detector or
StepOnePlus Real-Time PCR System (Applied Biosystems) with the universal cycling conditions. The mRNA levels were normalized to 18S rRNA and are presented as fold change (2 -∆∆Ct ) relative to control (MCF-7 Tet-Off TRPV1 + dox or MCF-7 tet-off). Fold change levels were calculated using the comparative threshold cycle Ct method [41, 42] . 
Measurement of intracellular free
Statistical analysis
GraphPad Prism Version 5.01 software (GraphPad Sotfware Inc) was used for the generation, 95 % confidence interval values and statistical significance were calculated as described in the figure legends.
Results
Generation of an MCF-7 tet-off cell line over-expressing TRPV1 (MCF-7 tet-off TRPV1 ).
A breast cancer cell line model was developed to assess the consequences of overexpression of a calcium permeable ion channel in breast cancer cells and the optimal approach and conditions to therapeutically target such channels. The MCF-7 cell line was selected because MCF-7 cells have low levels of TRPV1, a calcium permeable ion channel with well characterized pharmacological modulators (e.g. capsaicin). The TRPV1 over expressing MCF-7 cell line was generated using a plasmid with a bi-directional promoter that expressed both TRPV1 and -gal in the absence of dox. More than 50 stables lines were generated; for the other two clones (Fig S3C and D) .
Assessment of TRPV1-mediated increases in [Ca
Assessment of the effects of TRPV1 activation on cell viability and dependence on TRPV1
expression levels.
The effect of capsaicin on viable cell number was assessed using an MTS assay in the MCF-7 tet-off TRPV1 ( Fig. 3A and B) and MCF-7 tet-off parental cell lines ( viability with capsaicin treatment [45] , however 0.1 nM and 100 µM capsaicin had the same ability to inhibit cell viability, which is not consistent with the results of other studies [26] .
Furthermore, the role of TRPV1 in the effect of capsaicin on MCF-7 cells was not conclusively demonstrated [45] .
The level of TRPV1 over-expression required to affect MCF-7 viable cell numbers in the presence of capsaicin was then tested. The concentration response curve showed that TRPV1 over-expression clearly sensitized MCF-7 cells to the effects of 3 μM capsaicin (EC 50 = 0.119 ng/mL dox) (Fig. 4 , and Fig. S5A and B).
Overexpression or activation of TRPV1 does not promote proliferation of MCF-7 cells.
MCF-7 cell proliferation was assessed with increasing levels of TRPV1 over-expression without the addition of capsaicin. The growth curves show that the over-expression of TRPV1 had no effect on MCF-7 proliferation (Fig. 5A ).
Activation of TRPV1 could promote proliferation if the nature of the [Ca 2+ ] i signal was appropriate for proliferative signaling. Such activation of proliferation could limit the use of ion channel activation in cancer therapy. However, at no levels of TRPV1 expression did capsaicin produce an increase in cell numbers at 48 h (Fig. 5B ) or 96 h (Fig. 5C ). Instead, consistent with the results presented above, high levels of TRPV1 over-expression (e.g. 0 ng/mL and 0.1 ng/mL dox) with sub-maximal capsaicin (3 M) reduced the number of viable MCF-7 tet-off TRPV1 cells ( Fig. 5B and C) .
Activation of TRPV1 induces cell death in MCF-7 cells that over-express TRPV1
To further assess the capsaicin-mediated reduction in cell number in TRPV1 overexpressing MCF-7 tet-off TRPV1 cells, a cell death assay was performed using three fluorescent dyes, staurosporin induces apoptosis in various cell types including MCF-7 cells [46, 47] . Phase contrast images show characteristic necrotic morphology for the capsaicin treated cells, compared to the apoptotic morphology observed in the staurosporin treated cells (Fig. 6A ) [48] . The fluorescent images show that the capsaicin treated cells are mostly positive for YO-PRO-1 and PI, and only a few cells were positive for YO-PRO-1 but not PI, indicating necrosis ( Fig 6A) , whereas many of the staurosporin treated cells were positive for YO-PRO-1 but not PI, indicating early apoptosis (Fig 6A) . Quantification of the staining showed that capsaicin (0.3 -3.0 M) and staurosporin (0.1 -3.0 M) both induced cell death in MCF-7 tet-off TRPV1 cells overexpressing TRPV1 (Fig. 6B) . However, staurosporin (3 M) was associated with 8% of cells being YO-PRO-1 positive and PI negative populations indicating apoptosis, but only 1% of cells were in this population with capsaicin (3 M) (Fig. 6C ) at 6 h.
Hence, capsaicin-induced cell death observed in cells over-expressing TRPV1 occurs via a mechanism primarily mediated by a necrotic pathway.
Since capsaicin activated TRPV1 is also permeable to Na + and Mg 2+ [49] , the dependence of capsaicin-mediated cell death on Ca 2+ influx was assessed. The addition of the Ca 2+ chelator BAPTA protected MCF-7 cells against capsaicin-induced cell death, demonstrating that the cell death effect of capsaicin is indeed calcium-dependent (Fig. S6 ).
Capsaicin induced cell death in MCF-7 cells is concentration dependent and contingent upon the level of TRPV1.
The effect of TRPV1 expression levels and capsaicin concentration on cell death was assessed in MCF-7 tet-off TRPV1 cells. . Consistent with a rapid necrotic cell death mechanism, similar results were observed at both 6 h ( Fig. 7A ) and 24 h (Fig. 7B ) of capsaicin exposure. The highest percentage of cell death (~80%) was observed with the highest TRPV1 expression level (0 ng/mL dox) and the highest concentrations of capsaicin (3 M and 500 M) (Fig. 7) .
Expression levels of TRPV1 that induced sub-maximal [Ca 2+ ] i increases (0.1 and 0.3 ng/mL dox) also resulted in a sub-maximal percentage of cell death (15-56%) when treated with capsaicin at 3 M or 500 M. As the expression level of TRPV1 increased, the concentration of capsaicin required to induce cell death decreased; for example with the highest level of TRPV1 expression (0 ng/mL dox) 0.3 M capsaicin induced cell death, while at a lower level of TRPV1 (0.3 ng/mL dox) 3 M capsaicin was required to induce cell death (Fig. 7 ). This suggests that the level of TRPV1 expression is a critical determinant of the capsaicin concentration required to induce cell death in breast cancer cells.
Activation of TRPV1 induced c-Fos and RIP3 expression
To further define the consequences of TRPV1 activation in MCF-7 breast cancer cells, the effect of activating overexpressed TRPV1 with capsaicin on c-Fos, a component of the early response transcription factor, AP-1 [50] , was assessed in MCF-7 tet-off TRPV1 cells. In the absence of TRPV1 overexpression (+ dox) capsaicin had no effect on c-Fos mRNA levels (Fig. 8A) . However, when TRPV1 expression was induced, c-Fos expression was elevated by capsaicin as early as 0.5 h, with highest levels observed at 3 h (Fig. 8A) . To further verify the induction of necrosis by capsaicin treatment in TRPV1 overexpressing MCF-7 cells the expression of a necrotic marker, RIP3 [51, 52] was assessed. At 12 h after capsaicin treatment the expression of RIP3 was elevated almost 2-fold in the presence compared to the absence of TRPV1 over-expression (Fig 8B) .
Discussion
The identification of ion channels with increased expression in some cancer cell lines and clinical samples, has led to the hypothesis that pharmacological modulators of these ion channels may represent potential therapies for specific cancers. Inhibition of ion channels has been the first focus for potential therapies with studies looking at the effectiveness of silencing specific ion channels or using pharmacological inhibitors to attenuate processes important in cancer progression such as proliferation, migration and invasion and to examine the importance of the calcium signal in cell cycle progression and motility. However, activation of ion channels to produce sustained high levels of [Ca 2+ ] i and subsequent cell death has also been proposed as a strategy and is supported by the constitutively active TRPL [25] and the non-selective TRPM8 activator menthol [53] producing cell death in LNCaP prostate cancer cells that overexpress the Ca 2+ permeable ion channels TRPL [25] or TRPM8 [17] , respectively.
Targeting overexpressed ion channels through pharmacological activation could potentially potentiate cellular proliferation at low concentrations in cancer cells that do not overexpress the calcium channel sufficiently such that activation produces cell death [28, 39] . Our studies Although TRPV1 dependent, the EC 50 for cell death for capsaicin was higher than for peak [Ca 2+ ] i . This indicates that the level of ion channel overexpression is likely to be a critical determinant of the therapeutic effectiveness of a calcium permeable ion channel activator in cancer therapy. The assessment of the degree of ion channel overexpression will therefore be important in identifying patient groups for such therapies. Although capsaicin mediated cell death is reported in some cancer cell lines, in many cases the concentrations used were well above those used in this study and could be due to the non TRPV1-mechanisms that have been reported at high concentrations of capsaicin [26, 40] .
The identification of other calcium permeable ion channels with pronounced overexpression High content analysis of PI and YO-PRO-1 permeability and differences with staurosporin effects and the rapid nature of cell death (6 h) is consistent with a rapid loss of the maintenance of critical ion gradients, the loss of plasma membrane integrity and induction of necrosis. Furthermore, the morphology of the capsaicin treated cells compared to the staurosporin treated cells and the elevated RIP3 expression in capsaicin treated cells with TRPV1 over-expression, indicate induction of necrotic cell death [48, 51] . Necrotic cell death can be induced by increased intracellular calcium [59] , consistent with our findings. Necrosis is traditionally considered uncontrolled cell death, however, programmed necrosis has been suggested [60] [61] [62] . Necrosis can be induced in cancer cells by DNA alkylating agents, irradiation and by photodynamic treatment [63] [64] [65] . Indeed, in breast cancer patients anthracyclin predominately induces necrotic cell death [66] . Photodynamic treatment induces cell death in an apoptotic-resistant breast cancer cell line [64] , suggesting that treatments that induce necrotic cell death may be effective for tumors with defective apoptotic pathways [62, 67] .
The early response gene, c-Fos was initially considered as a promoter of proliferation and a proto-oncogene, however, more recent studies show that c-Fos also has a role in cell death [68, 69] . promote sensitivity to cell death inducers, such as seen for silencing of specific calcium efflux pump isoforms [22] . These studies also suggest that activating calcium permeable ion channels may be an effective tool to mediate breast cancer cell death, in a way that may bypass some resistance mechanisms. However, as yet no ion channel with sufficiently high endogenous levels has yet been characterised in a breast cancer cell line and the consequences of sustained ion channel activation warrants further study. The expansion of available pharmacological activators of ion channels and the identification of other Ca 2+ channel overexpressed in specific cancers may allow the eventual development of oncology agents that act via this mechanism.
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